ERBB2 and breast carcinoma: One of the emodin derivatives, 10-(4-acetamidobenzylidene)-9-anthrone, was found to be more potent than emodin in suppressing the tyrosine phosphorylation of p185neu and inhibiting the proliferation and transformation of HER-2/neu-overexpressing human breast cancer cells.